Moderate sodium restriction with angiotensin converting enzyme inhibitor in essential hypertension: a double blind study.
G. A. MacGregor, Giuseppe A. Sagnella(Charing Cross Hospital), Francesco P. Cappuccio(University Hospitals Coventry and Warwickshire NHS Trust), Angela C. Shore(University of Exeter), DRJ Singer(The University of Sydney), Nirmala D. Markandu(University of London)
Cited by 90
Related Papers
Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies
|The Lancet Diabetes & Endocrinology|2018|340